Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The objectives of this study were to demonstrate comparable safety and efficacy of
Terconazole Vaginal Suppositories, 80 mg and fluconazole in the treatment of subjects with
severe vulvovaginal candidiasis.